Korsana Biosciences, Inc.(KRSA)

Biotechnology · Waltham, MA

$31.77+1.05 (+3.42%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T20:12:17.312Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:12:17.312Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 31.77
Unrounded diluted TTM EPS · period ending 2026-06-30: -12.04

FMP input reference: a391670e5a4a022aad0cee8204cefb21b4613c0a4e77d467850b61b24c11a6b7

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

KRSA PE Ratio Metrics

PE RATIO

N/A

KRSA Competitors' PE Ratio

KRSA

Korsana Biosciences, Inc.

Current

Market Cap

$148.73M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VYGR

Voyager Therapeutics, Inc.

vs KRSA

Market Cap

$148.64M

PE Ratio

N/A

TTM Avg

12.24

3Y Avg

8.04

5Y Avg

7.33

AVXL

Anavex Life Sciences Corp.

vs KRSA

Market Cap

$148.27M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALXO

ALX Oncology Holdings Inc.

vs KRSA

Market Cap

$146.67M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ABOS

Acumen Pharmaceuticals, Inc.

vs KRSA

Market Cap

$146.62M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CDXS

Codexis, Inc.

vs KRSA

Market Cap

$146.28M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FBIOP

Fortress Biotech, Inc.

vs KRSA

Market Cap

$146.27M

PE Ratio

6.93

TTM Avg

6.25

3Y Avg

6.25

5Y Avg

6.25

VRXA

Veraxa Biotech Holding AG

vs KRSA

Market Cap

$152.72M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRDL

Cardiol Therapeutics Inc.

vs KRSA

Market Cap

$152.74M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MENS

Jyong Biotech Ltd. Ordinary Shares

vs KRSA

Market Cap

$153.58M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Korsana Biosciences, Inc. (KRSA)	$148.73M	N/A	N/A	N/A	N/A
Voyager Therapeutics, Inc. (VYGR)vs ›	$148.64M	N/A	12.24	8.04	7.33
Anavex Life Sciences Corp. (AVXL)vs ›	$148.27M	N/A	N/A	N/A	N/A
ALX Oncology Holdings Inc. (ALXO)vs ›	$146.67M	N/A	N/A	N/A	N/A
Acumen Pharmaceuticals, Inc. (ABOS)vs ›	$146.62M	N/A	N/A	N/A	N/A
Codexis, Inc. (CDXS)vs ›	$146.28M	N/A	N/A	N/A	N/A
Fortress Biotech, Inc. (FBIOP)vs ›	$146.27M	6.93	6.25	6.25	6.25
Veraxa Biotech Holding AG (VRXA)vs ›	$152.72M	N/A	N/A	N/A	N/A
Cardiol Therapeutics Inc. (CRDL)vs ›	$152.74M	N/A	N/A	N/A	N/A
Jyong Biotech Ltd. Ordinary Shares (MENS)vs ›	$153.58M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$31.77

Forward EPS (Est.)

$-3.27

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

KRSA PE Ratio Metrics

KRSA Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics